Biological mercury measurements before and after administration of a chelator (DMPS) and subjective symptoms allegedly due to amalgam

European Journal of Oral Sciences

Volumn 108, Issue 6, 2000, Pages 511-522

  Schuurs, Albert ^a   Exterkate, Rob ^a   Ten Cate, Bob ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Chelating agent; Dental amalgam; Health; Mercury

Indexed keywords

CHELATING AGENT; DENTAL ALLOY; MERCURY; PLACEBO; UNITHIOL;

ADULT; ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; ATTITUDE TO HEALTH; BLOOD; CHEMICALLY INDUCED DISORDER; CHEWING GUM; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DENTAL SURGERY; DOUBLE BLIND PROCEDURE; DRINKING BEHAVIOR; FATIGUE; FEEDING BEHAVIOR; FISH; HEADACHE; HUMAN; MEMORY DISORDER; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; SMOKING; TASTE DISORDER; URINE;

ADULT; ALCOHOL DRINKING; ANALYSIS OF VARIANCE; ANIMALS; ATTITUDE TO HEALTH; CHELATING AGENTS; CHEWING GUM; CHI-SQUARE DISTRIBUTION; DENTAL AMALGAM; DENTAL RESTORATION, PERMANENT; DOUBLE-BLIND METHOD; FATIGUE; FISHES; FOOD HABITS; HEADACHE; HUMANS; LEAST-SQUARES ANALYSIS; MEMORY DISORDERS; MERCURY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PLACEBOS; REGRESSION ANALYSIS; SMOKING; TASTE DISORDERS; UNITHIOL;

EID: 0034576982     PISSN: 09098836     EISSN: 16000722     Source Type: Journal    
DOI: 10.1034/j.1600-0722.2000.00880.x     Document Type: Article

References (89)

1. SANDBORGH-ENGLUND G, BLINDER CG, JOHANSON G, LIND B, SKARE I, EKSTRAND J. The absorption, blood levels, and excretion after a single dose of mercury vapor in humans. Toxicol Appl Pharmacol 1998; 150: 146-153.
2. MAGOS L. Mercury metabolism and toxicology. In: HØRSTED-BINDSLEV P, MAGOS L, HOLMSTRUP P, ARENHOLT-BINDSLEV D, eds. Dental amalgam - a health hazard? Copenhagen: Munksgaard, 1991; 11-32.
3. MACKERT JR, BERGLUND A. Mercury exposure from dental amalgam fillings: Absorbed dose and the potential for adverse health effects. Crit Rev Oral Biol Med 1997; 8: 410-436.
4. COMMISSION OF THE EUROPEAN UNION, AD Hoc WORKING GROUP. Dental amalgam. Brussels: Commission of the European Union 1997.
5. LAINE J. Oral adverse reactions to dental amalgam and gold. Turku: Turun Yliopistpo, 1999.
6. MAREK. M. The release of mercury from dental amalgam: The mechanism and in vitro testing. J Dent Res 1990; 69: 1167-1174.
7. BRUNE D. Corrosion of amalgams. Scand J Dent Res 1981; 89: 506-514.
8. OLSSON S, BERGLUND A, BERGMAN M. Release of elements due to electrochemical corrosion of dental amalgam. J Dent Res 1994; 73: 33-43.
9. BRUNE D, GJERDET N, PAULSEN G. Gastrointestinal and in vitro release of copper, cadmium, indium, mercury and zinc from conventional and copper-rich amalgams. Scand J Dent Res 1983; 91: 66-71.
10. BRUNE D, EVKE DM. Man's mercury loading from dental amalgam. Sci Total Environ 1985; 44: 51-63.
11. HEINTZE U, EDWARDSSON S, DERAND T, BIRKHED D. Methylation of mercury from dental amalgam and mercuric chloride by oral streptococci in vitro. Scand J Dent Res 1983; 91: 150-152.
12. EDWARDS T, MCBRIDE BC. Biosynthesis and degradation of methylmercury in human faeces. Nature 1975; 253: 462-464.
13. CHANG S-B, SIEW C, GRUNINGER SE. Factors affecting blood mercury concentrations in practicing dentists. J Dent Res 1992; 71: 66-74.
14. BERGLUND A. Estimation by a 24-hour study of the daily dose of intra-oral mercury vapor inhaled after release from dental amalgam. J Dent Res 1990; 69: 1646-1651.
15. OLSSON S, BERGMAN M. Daily dose calculations from measurements of intra-oral mercury vapor. J Dent Res 1992; 71: 414-423.
16. BERGLUND A, MOLIN M. Mercury vapor release from dental amalgam in patients with symptoms allegedly caused by amalgam fillings. Eur J Oral Sci 1996; 104: 56-63.
17. LORSCHEIDER FL, VIMY MJ, SUMMERS AO. Mercury exposure from "silver" tooth fillings: emerging evidence questions a traditional dental paradigm. FASEB J 1995; 9: 504-508.
18. RICHARDSON GM, ALLAN M. A Monte Carlo assessment of mercury exposure and risks from dental amalgam. Hum Ecolog Risk Assessment 1996; 2: 709-761.
19. RICHARDSON GM. Assessment of mercury exposure and risks from dental amalgam. Final report. Medical Devices Bureau, Environmental Health Directorate, Health Canada, 1995, 56.
20. CONSEIL D'EVALUATION DES TECHNOLOGIES DE LA SANTÉ DU QUEBEC. The safety of dental amalgam: a state of the art review. Montreal: Conseil D'evaluation des Technologies de la Santé du Quebec, 1997.
21. BARREGÅRD L, SĀLLSTEN G, JĀRVHOLM B. People with high mercury uptake from their own dental amalgam fillings. Occup Environ Med 1995; 52: 124-128.
22. LANGWORTH S, STRŌMBERG R. A case of high mercury exposure from dental amalgam. Eur J Oral Sci 1996; 104: 320-321.
23. GEBEL T, DUNKELBERG H. Einfluss des Kaugummikonsums sowie einer dentalen Nachbarschaft von Amalgamfüllungen zu metallischen Restaurationen anderer Art auf dem Quecksilberuringehalt. Zbl Hyg 1996; 199: 69-75.
24. SĀLLSTEN G, THOREN J, BARREGÅRD L, SSCHUTZ A, SKARPING G. Long-term use of nicotine chewing gum and mercury exposure from dental amalgam fillings. J Dent Res 1996; 75: 594-598.
25. NYLANDER M. Mercury in pituitary glands of dentists. Lancet 1986; 22: 442.
26. NYLANDER ML, FRIBERG D, EGGLESTON L, BJÖRKMAN L. Mercury accumulation in tissues from dental staff and controls in relation to exposure. Swed Dent J 1989; 13: 235-243.
27. WHO. Environmental health criteria 118. Inorganic mercury. Geneva: World Health Organization, 1991.
28. BÖRJESSON J, BARREGÅRD L, SĀLLSTEN G, SCHŪTZ A, JONSON R, ALPSTEN M, MATTSON S. In vivo XRF analysis of mercury: the relation between concentrations in the kidney and urine. Phys Med Biol 1995; 40: 413-426.
29. MOLIN M, BERGMAN B, MARKLUND SL, SCHÜTZ A, SKERFVING S. Mercury, selenium, and glutathione peroxidase before and after amalgam removal in man. Acta Odontol Scand 1990; 48: 189-202.
30. CASCORBI IC, KNORR U, SCHIELE R, PETSCHELT A. Ergebnisse aus Erlanger Untersuchungszentrum Amalgam. Dtsch Zahnärztl Zeit 1992; 49: 936-939.
31. HICKEL R, WILD J, MARTUS P, SCHIELE R. Die Quecksilberbelastung von Zahnmedizinstudenten nach beruflicher Amalgamexposition. Deutsch Zahnärtzl Zeit 1995; 50: 506-510.
32. OLLSTAD ML, HOLLAND RI, WANDEL N, HENSTEN PETTERSEN A. Correlation between amalgam restorations and mercury concentrations in urine. J Dent Res 1987; 66: 1179-1182.
33. SANDBORGH-ENGLUND G, ELINDER C-G, LANGWORTH S, SCHŪTZ A, EKSTRAND J. Mercury in biological fluids after amalgam removal. J Dent Res 1998; 77: 615-624.
34. ROELS H, ABDELADIM S, CEULEMANS E, LAUWERYS R. Relationships between the concentration of mercury in air and in blood or urine in workers exposed to mercury vapour. Am Occup Hyg 1987; 31: 135-145.
35. BARREGÅRD L. Biological monitoring of exposure to mercury vapor. Scand J Work Environ Health 1993; 19 (Suppl 1): 45-49.
36. MOLIN M, SCHUTZ A, SKERFING S, SĀLLSTEN G. Mobilized mercury in subjects with varying exposure to elemental mercury vapour. Int Arch Occup Environ Health 1991; 63: 187-192.
37. SVENSSON B-G, SCHŪTZ A, NILSSON A, ÅKESSON I, ÅKESSON B, SKERFVING S. Fish as a source of exposure to mercury and selenium. Sci Total Environ 1992; 126: 61-74.
38. MARTINA R. Vitaal zonder giftige vullingen. Blaricum: Andriomeda, 1998.
39. PLANAS-BOHNE F. The effect of 2,3-Dimercaptopropane-1-sulfonate and dimercaptosuccinic acid on the distribution and excretion of mercuric chloride in rats. Toxicol 1981; 19: 275-278.
40. AASETH J, JACOBSEN D, ANDERSEN O, WICKSTRØM E. Treatment of mercury and lead poisonings with dimercaptosuccinic acid and sodium dimercaptopropanesulfonate. Analyst 1995; 120: 853-854.
41. APOSHIAN MM, MAIORINO RM, XU Z, APOSHIAN HV (1996). Sodium 2,3-dimercapto-1-propanesulfonate (DMPS) treatment does not redistribute lead or mercury to the brain of rats. Toxicol 1996; 109: 49-55.
42. ZALUPS RK. Influence of 2,3-dimercaptopropane-1-sulfonate (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the renal disposition of mercury in normal and uninephrectomized rats exposed to inorganic mercury. J Pharmacol Exp Ther 1993; 267: 791-800.
43. SCHIELE R, KRÖNCKE A. Quecksilber-Mobilisation durch DMPS (Dimaval®) bei Personen mit und ohne Amalgamfüllungen. Zahnärtzl Mitteilungen 1989; 79: 1866-1868.
44. HICKEL R, MEIER R, RAAB W, PETSCHELT A. Nebemverkungen von Aamalgam? Eine interdisziplinare Studie. Dtsch Zahnärtzl Zeit 1991; 46: 542-544.
45. CASCORBI IC, KNORR U, SCHIELE R, PETSCHELT A. Ergebnisse aus dem Erlanger Untersuchungszentrum Amalgam. Dtsch Zahnärztl Zeitschr 1994; 49: 936-939.
46. SĀLLSTEN G, BARREGÅRD L, SCHUTZ A. Clearance half life of mercury in urine after the cessation of long term occupational exposure: influence of a chelating agents (DMPS) on excretion of mercury in urine. Occup Environ Med 1994; 51: 337-342.
47. SCHIELE R, SCALLER KH, WELTLE D. Mobilasation von Quecksilber-Speicherungen im Organismus mittels DMPS (Dimaval®). Arbeitsmed Sozialmed Präventivmed 1989; 24: 249-251.
48. KLEBER JJ, GANZERT M, ZILKER Th. Quecksilberkonzentration im Urin nach DMPS-Gabe: Korrelation zur Anzahl der Amalgamfüllungen. In: FRIBERG LT, SCHRAUZER GN, eds. Status quo and perspectives of amalgam and other dental materials. Stuttgart: George Thieme Verlag, 1995; 61-69.
49. APOSHIAN HV, BRUCE DC, ALTER W, DART RC, HURLBUT KM, APOSHIAN MM. Urinary mercury after administration of 2,3-dimercaptopropane-1-sulfonic acid: correlation with dental amalgam score. FASEB J 1992; 6: 2472-2476.
50. GEODFREY M, CAMPBELL N. Confirmation of mercury retention and toxicity using 2,3-dimercapto-1-propane-sulphonic acid sodium salt (DMPS). J Adv Med 1994; 7: 19-30.
51. ROELS HA, BOECKX M, CEULEMANS E, LAUWERYS RR. Urinary excretion of mercury after occupational exposure to mercury vapour and influence of the chelating agent meso-2,3-dimercaptosuccinic acid (DMSA). Br J Indust Med 1991; 48: 247-253.
52. PIIKIVI L, TOLONEN U. EEG findings in chlor-alkali workers subjected to low long term exposure to mercury vapour. Br J Indust Med 1989; 46: 370-375.
53. 0 among dentists. Neurotoxicol Teratol 1995; 17: 161-168.
54. FAWER RF, RIBEAUPIERRE DE Y, GUILLEMIN MP, BERODE M, LOB M. Measurement of hand tremor induced by industrial exposure to metallic mercury. Br J Indust Med 1983; 40: 204-208.
55. NGIM CH, FOO SC, BOEY KW, JEYARATNAM J. Chronic neurobehavioural effects of elemental mercury in dentists. Br J Indust Med 1992; 49: 782-790.
56. BOOGAARD PJ, HOUTSMA AT, JOURNÉE HL, SITTERT VAN NJ. Effects of exposure to elemental mercury on the nervous system and kidney of workers producing natural gas. Arch Environ Health 1996; 51: 108-115.
57. LANGWORTH S, SĀLLSTEN G, BARREGÅRD L, CYNKIER I, LIND M-L, SÖDERMAN E. Exposure to mercury vapor and impact on health in the dental profession in Sweden. J Dent Res 1997; 76: 1397-1404.
58. NILLSON B, GERUARDSSON L, NORDBERB GF. Urine mercury levels and associated symptoms in dental personell. Sci Total Environ 1990; 94: 179-185.
59. USDHHS, PHS. Dental amalgam: a scientific review and recommended public health service strategy for research, education and regulation. Washington, DC: USDHHS, PHS, 1993.
60. STǑRTEBECKER P. Mercury poisoning from dental amalgam - a hazard to human brain. Stockholm: Störtebecker Foundation for Research, 1985.
61. ZIFF S. Silver denial fillings. The toxic time bomb. New York: Aurora Press, 1984.
62. ARENHOLTZ-BINDSLEV D. Mercury and the dental patient. In: HØRSTED-BINDSLEV P, MAGOS L, HOLMSTRUP P, ARENHOLT-BINDSLEV D, eds. Dental amalgam - a health hazard? Copenhagen: Munksgaard, 1991; 41-61.
63. SCHUURS AHB, EIJKMAN MAJ, HOOGSTRATEN J. Opinies van patiënten over amalgaam. Ned Tijdschr Tandheelkd 1994; 101: 268-272.
64. ISACSSON G, BARREGÅRD L, SELDEN A, BODIN L. Impact of nocturnal bruxism on mercury uptake from dental amalgams. Eur J Oral Sci 1997; 105: 251-257.
65. KINGMAN A, ALBERTINI T, BROWN LJ. Mercury concentrations in urine and whole blood associated with amalgam exposure in a US military population. J Dent Res 1998; 77: 461-471.
66. GUO T, BAASNER J. Determination of mercury in urine by flow-injection cold vapour atomic absorption spectrometry. Anal Chim Acta 1993; 278: 189-196.
67. COOLEN HCCH, VAN RIJCKEVORSEL JLA, DUIVENVOORDEN HJ, SCHUURS AHB. A non-linear analysis of the preference for preservation of the teeth. Commun Stat Theor Meth 1985; 14: 437-450.
68. GEER VAN DE JP. HOMALS. Leiden: Department of Data Theory, University of Leiden, 1985; UG-85-02.
69. JONES DW (1999). Exposure or absorption and the crucial question of limits for mercury. J Can Dent Assoc 1999; 65: 42-46.
70. AHLQWIST M, BENGTSSON C, LAPIDUS L, BERGDAHL IA, SCHŪTZ A. Serum mercury concentration in relation to survival, symptoms, and diseases: results from the prospective population study of women in Gothenburg, Sweden. Acta Odontol Scand 1999; 57: 168-174.
71. HRUBY K, DONNER A. 2,3-Dimercapto-1-propanesulphonate in heavy metal poisoning. Med Toxicol 1987; 2: 317-323.
72. TORRES-ALANIS O, GARZA-OCANAS L, PINEYRO-LOPEZ A. Evaluation of urinary mercury excretion after administration of 2,3-dimercapto-1-propane sulfonic acid to occupationally exposed men. J Toxicol Clin Toxicol 1995; 33: 717-720
73. GONZALEZ-RAMIREZ D, MAIORINO RM, ZUNIGA-CHARLES M, Zu X, HURLBUT KM, JUNCO-MUNOZ P, APOSHIAN MM, DART RC, DIAZ GAMA JH, ECHEVERRIA D. Sodium 2,3-Dimercaptopropane-1-sulfonate challenge test for mercury in humans: II. Urinary mercury, porhyrins and neurobehavorial changes of dental workers, in Monterrey, Mexico. J Pharmacol Exp Ther 1995; 272: 264-274.
74. GONZALEZ-RAMIREZ D, ZUNIGA-CHARLES M, NARRO-JUAREZ A, MOLINA-RECIO Y, HURLBUT KM, DART RC, APOSHIAN HV. DMPS (2,3-dimercaptopropane-1-sulfonate, dimaval) decreases the body burden of mercury in humans exposed to mercurous chloride. J Pharmacol Exp Ther 1998; 287: 8-12.
75. GRANDJEAN P, GULDAGER B, LARSEN IB, JORGENSON PJ, HOLMSTRUP P. Placebo response in environmental disease. Chelation therapy of patients with symptoms attributed to amalgam fillings. J Occup Environ Med 1997; 39: 707-714.
76. AMERICAN PSYCHIATRIC ASSOCIATION. Diagnostic and statistical manual of mental disorders, 4th edition (DSM-IV). Washington DC: APA, 1994.
77. MŪLLER-FAHLBUSCH H, WÖHNING Th. Psychosomatische Untersuchung der mit Amalgamfüllungen in Verbindung gebrachten Beschwerden. Dtsch Zahnärtzl Zeit 1983; 38: 665-659.
78. JONTELL M, HARALDSON T, PERSSON LO, ÖHMAN SC. An oral and psychosocial examination of patients with presumed oral galvanism. Swed Dent J 1985; 9: 175-178.
79. HENNINGSSON M, SUNDBOM E. Defensive characteristics in individual with amalgam illness as measured by the percept-genetic method Defense Mechanism Test. Acta Odontol Scand 1996; 54: 176-181.
80. MALT UF, NERDRUM P, OPPEDAL B, GUNDERSEN R, HOLTE M, LÖNE J. Physical and mental problems attributed to dental amalgam fillings: A descriptive study of 99 self-referred patients compared with 272 controls. Psychosom Med 1997; 59: 32-41.
81. SIBLERUD RL, MOTL J, KIENHOLZ E. Psychometric evidence that mercury from silver dental fillings may be an etiological factor in depression, excessive anger, and anxiety. Psychol Rep 1994; 74: 67-80.
82. BRATEL J, HARALDSON T, OTTOSSON J-O. Potential side effects of dental amalgam restorations. (II). No relation between mercury levels in the body and mental disorders. Eur J Oral Sci 1997; 105: 244-250.
83. SANDBORGH ENGLUND G, DAHLQVIST R, LINDELÖF B, SÖDERMAN E, JONZON B, VESTERBERG O, LARSSON KS. DMSA administration to patients with alleged mercury poisoning from dental amalgams: a placebo controlled study. J Dent Res 1994; 73: 620-628.
84. KARK RAP (1994). Clinical and neurochemical aspects of inorganic mercury intoxication. In: VINKEN PJ, BRUYN GW, eds. Handbook of clinical neurology, Volume 64. Amsterdam: Elsevier, 1994; 367-411.
85. VOKAC Z, GUNDERSEN N, MAGNUS P, JEBENS E, BAKKA T. Circadian rhythmicity of the urinary excretion of mercury, potassium and catecholamines in unconventional shift-work systems. Scand J Work Environ Health 1980; 6: 188-196.
86. BRUNE D, NORDBERG GF, VESTERBERG O, GERHARDSSON L, WESTER PO. A review of normal concentrations of mercury in human blood. Sci Total Environ 1991; 100: 235-282.
87. EKSTRAND J, BJÖRKMAN L, EDLUND C, SANDBORGH-ENGLUND G. Toxicological aspects on the release and systemic uptake of mercury from dental amalgam. Eur J Oral Sci 1998; 106: 678-686.
88. GERHARD I, WALDBRENNER P, THURA H, RUNNEBAUM B. Diagnostik von Schwermetallbelastungen mit dem peroralen DM PS-Test und dem Kaugummitest. Zeitschr Klin Labor 1992; 9: 404-41.
89. GRAZIANO JH. Role of 2,3-Dimercaptosuccinic acid in the treatment of heavy metal poisoning. Med Toxicol 1986; 1: 155-162.